Lefevre is certainly the one who knows the correct answer but from my understanding they need FDA approval for reimbursement but should be able to sell it without it. An IND is needed for novel technologies, not sure if this one qualifies as an improvement or a brand new tech that needs all the stages from pre-clinical to ph 2/3.
GLTA
- Forums
- ASX - By Stock
- Ann: BCAL Commences US Operations
BDX
bcal diagnostics limited
Add to My Watchlist
0.00%
!
6.9¢

Lefevre is certainly the one who knows the correct answer but...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.25M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3024 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 15302 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3024 | 0.066 |
3 | 67352 | 0.065 |
1 | 15000 | 0.064 |
1 | 79365 | 0.063 |
1 | 17591 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 15302 | 1 |
0.073 | 95048 | 1 |
0.075 | 682945 | 1 |
0.084 | 11764 | 1 |
0.089 | 36534 | 1 |
Last trade - 16.21pm 22/07/2025 (20 minute delay) ? |
Featured News
BDX (ASX) Chart |